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ABSTRACT
Palacio, Luis A. Ph.D., Purdue University, May 2020. SMALL ANGLE SCATTER-
ING OF LARGE PROTEIN UNITS UNDER OSMOTIC STRESS. Major Professor:
Horia I. Petrache.
Large protein molecules are abundant in biological cells but are very difficult
to study in physiological conditions due to molecular disorder. For large proteins,
most structural information is obtained in crystalline states which can be achieved
in certain conditions at very low temperature. X-ray and neutron crystallography
methods can then be used for determination of crystalline structures at atomic level.
However, in solution at room or physiological temperatures such highly resolved de-
scriptions cannot be obtained except in very few cases. Scattering methods that can
be used to study this type of structures at room temperature include small-angle
x-ray and neutron scattering. These methods are used here to study two distinct
proteins that are both classified as glycoproteins, which are a large class of proteins
with diverse biological functions. In this study, two specific plasma glycoproteins
were used: Fibrinogen (340 kDa) and Alpha 1-Antitrypsin or A1AT (52 kDa). These
proteins have been chosen based on the fact that they have a propensity to form
very large molecular aggregates due to their tendency to polymerize. One goal of
this project is to show that for such complex structures, a combination of scattering
methods that include SAXS, SANS, and DLS can address important structural and
interaction questions despite the fact that atomic resolution cannot be obtained as in
crystallography. A1AT protein has been shown to have protective roles of lung cells
against emphysema, while fibrinogen is a major factor in the blood clotting process.
A systematic approach to study these proteins interactions with lipid membranes and
other proteins, using contrast-matching small-angle neutron scattering (SANS), small
xv
angle x-ray scattering (SAXS) and dynamic light scattering (DLS), is presented here.
A series of structural reference points for each protein in solution were determined by
performing measurements under osmotic stress controlled by the addition of polyethy-
lene glycol-1,500 MW (PEG 1500) in the samples. Osmotic pressure changes the free
energy of the molecular mixture and has consequences on the structure and the inter-
action of molecular aggregates. In particular, the measured radius of gyration (Rg)
for A1AT shows a sharp structural transition when the concentration of PEG 1500 is
between 33 wt% and 36 wt%. Similarly, a significant structural change was observed
for fibrinogen when the concentration of PEG 1500 was above 40 wt%. This analysis
is applied to a study of A1AT interacting with lipid membranes and to a study of
fibrinogen polymerization in the presence of the enzyme thrombin, which catalyzes
the formation of blood clots. The experimental approach presented here and the
applications to specific questions show that an appropriate combination of scattering
methods can produce useful information on the behavior and the interactions of large
protein systems in physiological conditions despite the lower resolution compared to
crystallography.
11. INTRODUCTION
Scattering methods that include x-ray, neutron, and visible light scattering are a
class of experimental physical methods used to obtain information on the structure
of materials that are either in solid or liquid crystalline (gel) states. Biological ma-
terials that are made primarily of amino acids (proteins), fatty acids (lipids), and
nucleotides (DNA) are classified as gel-like/colloidal/liquid-crystalline materials that
exhibit a significant degree of molecular disorder in aqueous solutions at room tem-
perature. Because of molecular disorder, while scattering measurements are often
straightforward, data analysis is very complex involving extensive numerical analysis
and a number of assumptions.
X-ray scattering is a method that is used primarily to investigate order struc-
tures such as crystals [1]. However, it can also be used to characterize less organized
materials by providing information on granularity, inhomogeneities, and in general
by providing a histogram of pairwise distances in the scatterer. Protein crystal-
lography [2, 3] relies on finding conditions in which proteins arrange themselves in
organized structures amenable to conventional x-ray [1, 4] or neutron scattering. In
crystallography, one collects scattered intensities over a wide range of angles that
correspond to lattice spacings from about 10 A˚ (typical of amino acid sizes) down
to 1 A˚ corresponding to atomic size. In contrast, in small-angle scattering [5–8], the
relevant scattering domain corresponds to much larger distances on the order of 102 A˚
corresponding to the size of protein domains comprising many amino acid units.
1.1 Chemical specificity versus material properties
In studying biological molecules one faces two complementary aspects. On one
hand, chemical compounds present in biological cells undergo chemical modifications
2over various timescales as a result of enzymatic reactions and other chemical reactions.
On the other hand, biological materials also exhibit physical properties that determine
the structural integrity as well as the softness and adaptability required for proper
biological function [9–11]. Lipid molecules, for example, are structural components
of cell boundaries (i.e. membranes) and at the same time also act as substrates for a
variety of enzymatic reactions such as the action of phospholipases, as well as acting
as targets for a large array of cellular signaling events [12]. Being relatively small,
(phospho)lipids can act as structural components only collectively by aggregating
together [13]. Individual lipids as such do not have intrinsic structural roles – their
large-number aggregates do.
The situation is more nuanced in the case of proteins. Many types of proteins
are large sequences of hundreds and thousands of amino acids and their structural
role is self-evident on the virtue of their sheer size, as for example in the case of
collagen [14–17] and of actin [18–20] which are protein materials formed by poly-
merization. Amyloid fibrils [21–29] are another example of protein aggregates with
macromolecular size. In essence, one can identify a structural role of proteins and
especially protein aggregates simply based on their large physical size. At the same
time, most known proteins are also participants in chemical reactions and/or molec-
ular binding events that are the basis of the so called “molecular recognition” or cell
signaling in biological systems. In such cases, proteins have been shown to have an
“active site” where this molecular recognition occurs. Typically, these active sites are
structurally small compared to the protein itself. One interesting question therefore
is why chemically active proteins are physically so much larger than the chemically
active site. Intuitively, the large size of the protein has the role to protect the active
site either from chemical degradation or physical perturbation. In support of this
interpretation, proteins have been shown to undergo significant structural changes
which can turn on or off the active site. Although the exact way in which the sheer
size of a protein “protects” its active site is not known, we work with the hypothesis
that the properties of the protein material must play an important role. By regard-
3ing the protein as a material rather than a particular chemical structure we focus on
non-specific material properties rather than chemical specificity.
1.2 Proteins
Proteins are macromolecules that can assume a variety of conformations depending
on environmental conditions such as pH, ionic strength (salt content), and temper-
ature. Proteins have essential biological functions related not only to their chemical
structure but also to their physical properties. A first level of classification distin-
guishes between water soluble and water insoluble proteins, called hydrophilic and
hydrophobic, respectively. At a finer detail, any given protein can contain hydrophilic
and hydrophobic domains. The interaction between these domains determines how
a protein behaves in the aqueous environment of cells [12, 23, 30–32]. At the next
level of classification, from a physical perspective, there are proteins that exist in
monomeric form (single units) and proteins that have aggregation tendencies to form
dimers, trimers, and even larger polymeric units. The ability and tendency of pro-
teins to aggregate and in some cases to form polymers has important consequences
on how they perform biological functions [2,33–37]. However, there is no general rule:
the aggregation of some proteins is beneficial to cells while the aggregation of others
is detrimental. In this project, we consider two representatives of proteins that are
prone to aggregation and polymerization: alpha-1 antitrypsin (A1AT) and fibrinogen.
A1AT (Fig. 1.1), with a molecular weight of 52kDa ( 400 amino acids) is a member
of a protein family called serpins [30,38–48]. It has been shown to have protective roles
of lung cells against emphysema, a disease characterized by lung tissue destruction.
[49–51]. Fibrinogen (Fig. 1.2), with a molecular weight 340 kDa ( 3000 amino acids)
is the building block of blood clots [42,45,52–57]. While biologically distinct, the two
proteins present similarities in biophysical studies due to their large size and their
aggregation and polymerization tendencies.
4Fig. 1.1. Crystal structure of alpha-1-antitrypsin in two types of represen-
tations: cartoon view (top) and spacefill view (bottom). PDB structure
2QUG. DOI: 10.2210/pdb2QUG/pdb.
1.3 Protein nanomaterials
Although inspired from biology, the main focus in this thesis is on the material
properties of protein structure and aggregates. This material perspective is a con-
5Fig. 1.2. Crystal structure of fibrinogen in two types of representations:
cartoon view (top) and spacefill view (bottom). PDB structure 3GHG.
DOI: 10.2210/pdb3GHG/pdb
sequence of current interest in industry and technology in nanomaterials [9–11, 14,
58–64]. The bioinspired branch of material engineering takes advantage of molecu-
lar constructs that (1) already exist in nature, (2) can be readily produced at large
scales and (3) have tunable material properties. Networks of polymerized or simply
aggregated proteins are excellent candidates for uncovering natural products for new
applications.
A number of physical methods are available to study and characterize soft, gel-like
materials. These include scattering methods such as x-ray, neutron, and visible as
well as force spectroscopy such as AFM. In this thesis, we use small-angle scattering
methods which are appropriate for scatterers that are much larger than the wave-
length of the radiation used in the measurement. As a reference, typical x-ray and
neutron wavelengths used in material research are on the order of 1−10 A˚, while pro-
tein aggregates have sizes that range from nanometers to microns. While small-angle
x-ray scattering (SAXS) and small-angle neutron scattering (SANS) are by now estab-
lished methods [3,8,35,65–72], the challenging aspect of this thesis is the heterogeneity
6and polydispersity of protein samples prone to aggregation and polymerization. In
other words, acquiring and analyzing scattering data involve considerations of sample
preparation history and polymerization conditions. In the case of fibrinogen, it is
well known from physiological and molecular studies that it polymerizes in the pres-
ence of an enzyme called thrombin forming a network aggregate call fibrin, essentially
the blood clot. For A1AT, polymerization seems to occur spontaneously in certain
conditions although there is no clear conclusion at this point. Misfolding and aggre-
gation of A1AT has been reported in a cell organelle called endoplasmatic reticulum
(ER). [51, 73] Some misfolding is concurrent with polymerization which then leads
to ”ER overload”, which is basically mechanical stress. Mutations in the amino acid
sequence of the protein might be responsible for this process.
The primary data for this project are small-angle x-ray scattering (SAXS) mea-
surements performed at the Advanced Photon Source (APS) at the Argonne National
Laboratory (ANL) and small-angle neutron scattering measurements (SANS) at the
Oak Ridge National Laboratory (ORNL). The EQ-SANS (BL6) instrument at ORNL
was used for SANS experiments [69], while SAXS data were collected at the X-ray
Operations and Research Beamline 12-ID-C at the APS. SAXS and SANS [71] are
complementary methods and each instrument has its own advantages and disadvan-
tages. Most notably, the intensity of a synchrotron beam is much higher than that of a
neutron source. This translates into short exposure times for SAXS experiments (or-
der of milliseconds), and long exposure times for SANS experiments (order of hours).
There are a few important advantages of SANS over SAXS: SANS does not result
on radiation damage of the sample, while SAXS does; SANS is sensitive to hydrogen
and to isotopes, while SAXS is not; and the penetration depth of neutrons is higher
than that of x-rays. Neutrons interact with the nuclei, the electron shell and in an
unsystematic way with the atomic number, depending on the direction of the nuclear
spin. X-rays interact with the electron shell and the interaction is proportional to the
atomic number of atoms. Hydrogen is virtually invisible to x-rays.
7Structural measurements in this project are performed for samples under osmotic
stress which is controlled by the addition of polyetylene glycol polymer (PEG). PEG
has been shown to have negligible specific interactions with biological molecules in-
cluding lipids, protein, and DNA, while acting as an effective osmolyte. Such an
approach is therefore appropriate for our goal here to study the non-specific material
properties of protein aggregates as opposed to chemical specificity.
82. THEORY
2.1 Small-angle Scattering
In this work we are only concerned with elastic scattering. This means that
there is no change in the wavelength λ and no change in momentum magnitude
ks = ki. However, the direction (orientation) of the momentum vector of the beam
upon interacting with the sample changes as
|~q| = |~ks − ~ki| = 4pi sin(θ)
λ
, (2.1)
where 2θ is the scattering angle. Figure 2.1 shows a schematic of scattering geometry.
Fig. 2.1. Schematics of small angle scattering setup.
The intensity of the scattered beam is given by
I(q) =
〈∣∣∣∣∫ (ρ(~r)− ρ¯s) ei~q·~r d~r ∣∣∣∣2
〉
, (2.2)
where ρ(~r) is the scattering length distribution (equal to the total scattering length
of the atoms per unit volume) and ρ(~r) − ρ¯s is the difference in scattering density
9between the volume element at position ~r and that of the solvent. The difference is
called the scattering contrast
∆ρ = ρ(~r)− ρ¯s. (2.3)
2.2 Radius of gyration
One convenient parameter used to measure the size of a solid object is its radius
of gyration which is defined as
R2g =
1
2
∫∞0 r2p (r) dr
∫∞0 p (r) dr
(2.4)
where p(r) is the length distribution function of the object. Note that this is not the
same as the physical boundary of the object. For example, for a solid and uniform
triaxial ellipsoid of semiaxes a, b, and c the square of the radius of gyration is
R2g =
1
5
(a2 + b2 + c2). (2.5)
For as sphere we have a = b = c = R and the formula reduces to
R2g =
3
5
R2. (2.6)
For a solid and uniform cylinder of radius r and length L, the square of the radius of
gyration is
R2g =
1
12
(3r2 + 4L2). (2.7)
These models are implemented in the Igor software used for fitting scattering data.
2.3 Guinier Approximation
The Guinier approximation is the results of truncating a power series expansion
which for globular molecules gives
I (q) = I (0) e−
q2R2g
3 (2.8)
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and which, in theory, is valid when
q2R2g
3
< 1. (2.9)
In practice, a safer limit of qmaxRg < 1.3 or even qmaxRg < 1 is considered when
scattering data are analyzed in this way. Where qmax is the maximum q value on the
range being considered for the Guinier fit. By taking the log of Eq. 2.8, we obtain
ln [I (q)] = ln [I (0)]− q
2R2g
3
. (2.10)
The Guinier approximation can be used to estimate the forward scattering I (0) by
extrapolation to low q and to obtain the radius of gyration Rg from the slope of the
ln [I (q)] vs. q2 plot.
2.4 Pair Distribution Function
A pair distribution function P (r) of inter-atomic distances can be obtained by
performing a Fourier transform of the scattering profile. Essentially, P (r) is a his-
togram of distances between all pairs of atoms in the scatterer and can be used to
detect changes in protein structure in real space. Boundary conditions are P (0) = 0
and P (Dmax) = 0, where Dmax is the upper limit for r and is usually estimated as
Dmax ≈ 3Rg. The zeroth moment of P (r) is the value I (0),
I (0) = 4pi ∫Dmax0 P (r) dr, (2.11)
while the second moment is related to the radius of gyration as given above in Eq. 2.4.
The value I (0) is proportional to the number of scattering particles N per unit volume
and the volume of the particle V ,
I(0) = N(∆ρ V )2 =
C(∆ρ)2v2MW
NA
, (2.12)
where MW is the molecular weight of the scattering particle, C is mass density, v is
the partial specific volume of the particle, NA is Avogadro’s number, and ∆ρ is the
density contrast.
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3. MATERIALS AND METHODS
3.1 Materials
A1AT (alpha1-proteinase inhibitor (human)) was purchased in purified powder
form from Baxter (Aralast). Phosphate Buffered Saline (PBS), 10X Solution, was
purchased from Fisher BioReagents. Fibrinogen and Thrombin were provided by Dr.
Elliott Rosen from the School of Medicine at Indiana University. PEG 1500 and PEG
400 (Poly-ethylene glycol average MW 1,500 and 400 respectively) were purchased
from Sigma-Aldrich in solid form. The lipids POPC (1-Palmitoyl-2-oleoylphospha-
tidylcholine), POPS (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine) and DLPC
(1,2-Dilauroyl-sn-glycero-3-phosphocholine) where purchased in purified power form,
and in cloroform solution from Avanti Polar Lipids. A1AT was stored at 4◦C and
fibrinogen at −80◦C. Lipids were stored at −20◦C for long terms (longer than 1-2
months) and at 4◦C for shorter periods. PEG was stored at room temperature.
3.1.1 A1AT Samples
A1AT samples were prepared by directly diluting the protein powder into prepared
buffer. For solutions containing A1AT and PEG, each solute was first dissolved at
high concentrations to make stock solutions and then later diluted and combined
to reach desired concentrations. 1X PBS (pH 7.4) was used for all samples that
contained proteins. Vortexing was used to mix samples. Some samples required
cycles of centrifugation and vortexing in order to create homogeneous mixtures. A
series of 4 mg/ml A1AT samples (at 40% D2O , to observe the PEG molecules) was
made by varying the concentration of PEG 1500 from 0 wt% to 50 wt%. All A1AT
measurement where done at 30◦C.
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3.1.2 Fibrinogen Samples
Because of the high propensity of fibrinogen to polymerization, even in the absence
of thrombin, these samples required to be kept at the lowest possible temperature
when not stored at −80◦C. Dry ice was used to keep the samples frozen during
transportation and before experiments were conducted. Transportation time to Oak
Ridge National Laboratory was approximately 6 hours, and transportation time to
Argonne National Laboratory was approximately 4 hours. Aliquots of fibrinogen
and thrombin were thawed and allowed to equilibrate for at least 30 minutes before
measurements, by placing them in a 30◦C bath.
3.1.3 Lipid samples
Lipids in chloroform were lyophilized over an 8 hour period to obtain a lipid pow-
der; which was then added to buffer solutions. Lipid dispersions were then vortexed
and put through freeze/thaw cycles to obtain a homogeneous distribution of lipid
vesicles [74]. Protein-lipid membrane samples were prepared by mixing (nominal con-
centrations) 4 mg/ml A1AT and 10 mg/ml lipid in 1X PBS solution. Mixtures were
then vortexed/centrifuged and stored at 4◦C. Before measurements, samples were
equilibrated at measurement temperature, and vortexed to obtain a homogeneous
sample that was added to capillaries (SAXS) and banjos (SANS) for measurement.
3.2 Experimental Methods
3.2.1 Small-angle X-ray Scattering
SAXS measurements were performed at the X-ray Operations and Research Beam-
line 12-ID-C at the Advanced Photon Source, Argonne National Laboratory. All of
the data were provided in frame (picture of the scattering) format, and as a 1-D
reduced text file ready to be analyzed.
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3.2.2 Small-angle Neutron Scattering
SANS measurements were performed at the EQ-SANS (BL6) instrument at Oak
Ridge National Laboratory (ORNL) in Oak Ridge, TN; during five beam-times awarded
under the Integrated Proposal Tracking System. These are IPTS-6362, IPTS-7367,
IPTS-8479, IPTS-9237, and IPTS-10118. All of the raw data was archived by the
U.S. Department of Energy under each beam-time IPTS number. Raw data files were
then reduced using Mantid software and the instrument parameters to produce the
1D text files that could be analyzed using Igor and SasView.
The EQ-SANS instrument has a detector on rails that allows for the sample to
detector distance to be adjusted and has choppers that allow for the user to adjust
the wavelength of the neutrons. Because of these adjustable parameters its Q range is
0.002 A˚
−1
- 1.4 A˚
−1
. The detector size is 1m x 1m, and has 192 tubes x 256 divisions;
for a detector resolution of 5.5mm x 4.3mm. This instrument offers a sample–to-
detector distance range of 1.3m – 9m, and has a bandwith of 3A˚ - 4.3A˚.
3.2.3 Dynamic Light Scattering
DLS measurements were done using a Malvern Zetasizer Nano ZS90 instrument
available in the INDI Center at IUPUI.
3.3 Data Analysis and Controls
3.3.1 Data analysis
Most data analysis was performed using the software Igor and its free variant
SasView together with data reduction packages provided by the Oak Ridge National
Laboratory for SANS and the Argonne National Laboratory for SAXS. For both SAXS
and SANS, analysis packages accounted for beamline geometry, beam wavelength, and
detector resolution and sensitivity.
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The 2D frame collected from the instrument is converted into a 1D scattering
curve (Fig. 3.1) by integrating over the scattering arc. The Argonne APS SAXS
instrument was set to collect data over 90 degrees. The purpose of using a quarter
of the frame was to obtain data over a larger Q range. This is possible because the
signal to noise ratio is usually strong enough that a full frame is not needed. The
1D curve is translated into a readable text file that can be used for analysis. The
reduction process also involves input of instrument parameters and various calibration
(i.e. empty cell, background, and transmission) files.
Guinier analysis of A1AT SAXS data: The SAS raw data were reduced from 2D
detector data to 1D by integration. Before fitting the data, the constant background
and buffer background were subtracted aligned at high Q (0.3 A˚
−1 − 0.5 A˚−1) and
subtracted. In the case of SAXS the buffer background also included solutes that
were not being subject to the investigation. Most of the small angle scattering (SAS)
data fitting and analysis was done using SasView 4.01. The KCL SAS Analysis
package of Igor Pro 6.01 was used for early experiments to perform Guinier analysis
and to compare of raw data of scattering curves. Figure 3.2 shows how Igor Pro was
used to extract Rg parameters from an A1AT concentration series. Fitting the data
using Igor Pro is a manual iteration process that takes a very long time to complete
compared to SasView, which has an automated process. Two types of data fittings
were done: shape independent and shape dependent. The shape independent models
were used to find radius of gyration (Rg) of the molecule being measured. The shape
dependent models used are solid sphere, ellipsoid, and cylindrical ellipsoid for which
fitting volumes were reported in order to compare between the different shapes.
Contrast matching: One of the advantages of using SANS to study a solution
with two different type of molecules is that the solvent can be prepared in a manner
where one of the molecule’s scattering contribution blends with that of the solvent
[53, 65, 67, 72, 75–77]. This in turn allows for the scattering contribution of the other
molecule to be observed. This is possible due to the scattering length of hydrogen
having an opposite sign (shift of pi of the phase on scattering) to that of deuterium,
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Fig. 3.1. SAXS 2D frame collected from the Argonne APS instrument
and reduced to a 1D scattering curve.
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Fig. 3.2. Example of a Guinier fit, for SANS A1AT in 100% D2O sample,
using Igor Pro 6.0.
and a different magnitude: bH = −0.374 · 10−12 cm and bD = 6.37 · 10−12 cm. A
prerequisite for the SANS osmotic stress experiments is to know the contrast match
point for the molecules that are present in the solution.
3.4 Lipid scattering
Multilamellar lipid vesicles (MLVs) give rise to interference peaks at angles given
by Bragg’s law for a 1D lattice:
2D sin θ = hλ, (3.1)
where D is the lattice spacing, θ is the angle of incidence, λ is the radiation wave-
length, and h is an integer number. The lattice spacing D is the average distance
between neighboring lipid membranes in the MLVs. The lipids used in this study
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Fig. 3.3. Examples of loaded fibrinogen (4.78 mg/ml) with thrombin (in
concentrations of 0.005, 0.01, 0.03, 0.5 and 2.0 unit/ml; from left to right)
samples into the banjo (quartz) holders for SANS measurements.
are in a fluid state at room temperature and therefore give rise to no more than 2
interference peaks, therefore h = 1, 2.
3.5 Optimization and controls
Some of the key issues for analysis of scattering data are 1) background controls,
2) relevant Q-range for data analysis, 3) scattering length matching (contrast) for
SANS, and 4) radiation damage.
1) Background controls. Fig. 3.6 shows one example of background measure-
ments for SAXS in which different glass capillaries were measured while loaded with
18
Fig. 3.4. Examples of cloudy samples of fibrinogen (4.3 mg/ml) mixed
with PEG 1500 (at 10 wt%, 20 wt%, and 30 wt%; from left to right) that
show protein aggregation.
the same H2O -1xPBS buffer solution. The exposure time for each sample was 0.2 sec
which was typical for our measurements at APS. All measurements were done using
Glass 50 capillaries, except otherwise specified.
The scattering profiles from glass capillaries loaded with buffer solution are clearly
not flat and needed to be subtracted appropriately from the scattering data during
data analysis. The functional form of the scattering curves is the same with and
without the PBS buffer which simplifies data analysis to some extent. There are
no major differences between the different types of capillaries except for different
absorption coefficients which are approximately constant in the measured Q-range.
Two of the scattering curves show “zingers” at high Q values which are sharp spikes
due to either detector electronics, direct scattering in the detector, or cosmic radiation.
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Fig. 3.5. Example of a fibrinogen sample after polymerization; showing
fibrin filaments.
These zingers are detected and eliminated by data analysis packages and do not affect
analysis results.
2) Relevant Q-range. As opposed to standard crystallography where scatter-
ing Bragg peaks are well defined, the analysis of SAXS profiles require testing the
robustness of data analysis results with the selection of the Q-range to be analyzed.
In principle, one aims to use the full range of scattering data, however there are a
number of limitations that need to be considered: 1) data close to the beam center
(low Q) are corrupted by overlap with the main beam and beam geometry, 2) data
close to detector edges (usually high Q) are corrupted by detector construction, and
3) the analysis of both small-angle scattering (both SAXS and SANS) rely on struc-
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Fig. 3.6. Background measurements for SAXS.
tural models and approximations. Items 1) and 2) are for the most part taken into
account by the analysis module available at each beamline. However, item 3) needs
to be investigated for each system. Fig. 3.7 shows one example of such analysis in
which an ellipsoid model was used to fit SAXS data. The plot shows the calculated
ellipsoid volume as a function of the maximum Q cutoff. From scanning the Qmax for
all samples in this concentration series it is clear that the upper limit of the Q range
needs to be above 0.3 A˚
−1
.
3) Scattering length matching. The contrast match point for lipids and pro-
teins are known to be 15% and 40% v/v D2O/H2O solvents, respectively (Madl et
al., 2011, Parsegian et al., 2000) (Table 1). These are the D2O/H2O v/v fraction that
need to be avoided when trying to observe either molecule using SANS. Because the
matching point of protein is near 40% D2O/H2O , it is important to accurately define
the contrast match point for PEG 1500. A contrast match experiment was done using
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Fig. 3.7. Ellipsoid volume as a function of the Qmax cutoff from a model
analysis using SasView for different samples. Qmin was kept constant at
0.01 A˚
−1
.
10 wt% of PEG 1500 in solution and by varying the volume fraction of D2O/H2O of
the solvent.
Figure 3.8 shows how the contrast match point for PEG 1500 was obtained. The
figure shows a plot of interpolated scattering intensity at Q = 0 for PEG solutions in
mixtures as a function of D2O fraction.The set of measurements include three points
under 20% and three points above 20% D2O/H2O solvent. The points were selected
this way because the theoretical estimate placed the match point between 15% and
20%. The square root of the forward scattering intensity I(0) is plotted versus the
D2O fraction of the solvent. Points below 20% D2O were inverted so that a linear
fit could be used to determine the match point of 16% D2O/H2O . The intersection
of data points with the line at I(0) = 0 indicates the point of scattering matching
between PEG 1500 and the D2O/H2O mixture (Contrast Match Point).
22
Fig. 3.8. Plot of interpolated scattering intensity at Q = 0 for PEG 1500
solutions in mixtures as a function of D2O fraction to determine matching
scattering length density. The contrast match point is at the intersection
of the data points with the line at 0 scattering intensity.
Table 3.1 shows the D2O/H2O ratios that match the molecules of interest in this
study, namely PEG 1500, protein, and lipid. While there are clearly differences in
the scattering density for different proteins (as well as for different lipids) based on
their chemical structures, these differences are negligible. Therefore current studies
use generic protein and lipid matching scattering lengths.
4) Radiation damage. Fig. 3.9 shows an example of radiation damage testing
for SAXS measurements of samples containing the A1AT protein and the POPC
lipid. The upper panel shows the full measured range, while the lower panel shows
a zoom on the lipid scattering portion. While there is no significant change in the
lipid scattering, the range of Q values corresponding to protein scattering shows
a systematic change versus time which is due to radiation damage. These control
measurements were used to set the maximum scanning time per sample.
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Table 3.1.
Scattering length matching for contrast measurements.
Molecule D2O : H2O ratio Source
PEG 1500 16% This work
Protein 40% Madl et al., 2011
Lipid 15% Parsegian et al., 2000
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Fig. 3.9. Radiation control of A1AT+POPC sample at 200 msec intervals.
Upper panel shows the full measured Q range and the lower panel shows
the scattering due to the POPC lipid.
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4. RESULTS
There are five sections of results as follows: 1) A1AT in solution, 2) A1AT under
osmotic stress, 3) A1AT and lipid, 4) Fibrin polymerization, and 5) Fibrinogen under
osmotic stress.
4.1 Scattering measurements of A1AT in solution
SAXS measurements of A1AT in H2O (1xPBS buffer) at 30
◦C are shown in
Fig. 4.1. The upper panel shows raw scattering curves that were processed only for
beam geometry and detector sensitivity while the lower panel shows the scattering
curves minus the background.
These samples were prepared within 30 hours of measurement in order to minimize
the effect of A1AT polymerization tendency. Constant backgrounds were extrapolated
from the range of Q values 0.3 A˚
−1
< Q < 0.4 A˚
−1
and the beam shape was subtracted
for low Q. Measurements were done at beam line 12 ID-C using glass capillaries (1.5 -
2 mm path) with exposure times of 200 msec per scan. Beamline parameters were as
follow: quantum energy was hω = 18KeV corresponding to λ = 0.6888 A˚, beam size
is horizontally 0.5 mm and vertically 0.3 mm, the detector has 1024 by 1024 pixels,
and the pixel size is 0.175 mm x 0.175 mm, and the sample detector distance is 2392
mm.
The figure shows that the scattering signal increases with increasing A1AT con-
centration as expected but the functional form does not change significantly as seen
in the lower panel that shows background subtracted scans.
The intensity at I(0) should linearly correlate to the concentration of the sample.
Fig. 4.2 shows an χ2 of 0.987. This graph was used to verify the concentration series
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Fig. 4.1. SAXS concentration series of A1AT in H2O 1xPBS measured
at 30◦C. Lower panel shows the scattering curves with the background
(capillary and H2O 1xPBS) subtracted.
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of samples and to insure there are no significant experimental artifacts that might
arise from both sample geometry and chemical composition.
Fig. 4.2. A plot of I(0) versus A1AT concentration.
Similar results are obtained from SANS measurements as shown in Fig. 4.3 which
like before shows raw scattering curves in the upper panel and background subtracted
curves in the lower pane. These experiments were done using a neutron wavelength
of 2.5 A˚, and a sample to detector distance of 4 m. For background subtraction, the
D2O scattering was used as shown in the upper panel for the two types of sample
holders (banjos) used in the experiment.
Fig. 4.4 shows SANS measurements of A1AT in solutions of different D2O /H2O
ratios used for scattering length contrast. The scattering was significantly weaker in
16% D2O which is likely due to 16% D2O being a closer to 40%, which is the match
point for A1AT.
The Patterson functions of pairwise distances are shown in Fig. 4.5. The blue curve
(2 mg/ml) represents the concentration in normal serum (i.e. 1.5 - 3.5 mg/ml). At
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Fig. 4.3. SANS of A1AT in D2O 1xPBS. Experiments done at EQ-SANS
beamline at ORNL-SNS.
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Fig. 4.4. SANS of A1AT in solution at different D2O/H2O ratios.
lower concentrations (1 to 15 mg/ml) the P (r) curves show a pronounced lobe centered
around 30 A˚ as well as local maxima around 90 A˚ and at 120 A˚. The secondary
maxima could be due to protein aggregation as these distances are multiples of the
first peak which shows the population of mostly diluted A1AT units.
Model analysis of scattering data provides values for the radius of gyration of
scattering units. These results are shown in Fig. 4.6 for 3 different models considered:
calculation from P (r), a Guinier model, and a Guinier-Porod model. Models converge
at higher concentrations and diverge at lower concentrations most likely due to low
scattering at low protein concentration.
Additional analysis can be performed using various shape models. Results are
shown in Fig. 4.7 for spherical, elliptical cylinder, and ellipsoidal shapes. This type
of analysis provides geometrical parameters of the shapes used as opposed the Rg
values. Fig. 4.7 shows the volumes of scattering units that allows a comparison of
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Fig. 4.5. Patterson functions (pair distance distributions) for the A1AT
concentration series obtained from SAXS.
different shapes. In order to compare with Rg values obtained before, the volume of
a uniform solid sphere as a function of Rg is
V =
4pi
3
(√
5
3
Rg
)3
. (4.1)
A spherical volume V ≈ 150, 000 A˚3 corresponds to Rg ≈ 26 A˚ indicating consistency
between the different models except for the ellipsoidal shapes.
Results can be compared with calculated SANS curves using the crystal structure.
This is shown in Fig. 4.8 and which yields an anticipated Rg = 21.2 A˚. Guinier fits to
the scattering data shown in Fig. 4.4 yield 27.1 A˚± 0.35 A˚ for the 16% D2O sample,
and 22.8 A˚±0.035 A˚ for the 100% D2O sample. The 4.3 A˚ difference between the two
results is not clear, however, the lower Rg value is more consistent with the theoretical
expectation.
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Fig. 4.6. SAXS Analysis of Rg using different models for the concentration
series of A1AT samples.
4.2 A1AT under osmotic pressure
Measurements under osmotic stress can provide additional structural information
[67, 78, 79]. The best experimental method to apply a well-controlled osmotic stress
is by using polymers such as PEG at known concentration. The higher the polymer
concentration, the higher the osmotic pressure applied on the protein. For each type
of polymer one usually has a choice for the range of molecular weights (MW) to be
used. Lower MW polymer, such as PEG 400 has the advantage that high osmotic
pressures can be achieved at relatively lower polymer concentration. The disadvantage
is that smaller polymer units might intercalate with the protein. Larger MW polymer,
such as PEG 20000 is usually used with membranes due to exclusions effects (lack
in intercalation) between scattering units. However, solutions of large MW polymers
are very viscous and gel-like making sample preparation and homogenization very
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Fig. 4.7. Volume analysis of A1AT for three different shape models.
difficult. For this work, we have use PEG 1500 as a compromise. However, even for
this intermediate MW, we found that A1AT samples had to be pre-diluted before
adding them to PEG solutions. Sample preparation was done by first diluting the
A1AT in water and then mixing the A1AT in solution with PEG in solution at 30◦C.
Fig. 4.9 gives an example of a comparison between sample preparations that used pre-
diluted A1AT in water and preparations without pre-dilution (A1AT powder added
directly to PEG solutions).
SANS scans of samples made without pre-dilution were lacking the expected pro-
tein scattering at low Q. For this reason, all samples used for data analysis were
prepared with pre-dilution. Fig. 4.10 shows SANS data of pre-diluted A1AT under
osmotic stress.
The corresponding Rg values using Igor Pro Guinier fits are shown in Fig. 4.11.
Rg values decrease as the PEG concentration increases to about 35% after which it
increases abruptly at 40% and 50% PEG. This result shows that the effect of osmotic
33
Fig. 4.8. Calculated SANS curve for A1AT using the x-ray crystal struc-
ture (2QUG) and the program CRYSON.
pressure is to initially compress the A1AT structure without inducing aggregation fol-
lowed by aggregation at high osmotic pressure. The measured aggregation threshold
at 30% PEG corresponds to the osmotic pressure value where the effect of protein-
protein attraction overcomes entropic effects.
SAXS also detects the effect of osmotic pressure on A1AT structures. These are
shown in in Fig. 4.12. Although the general trend is similar to SANS data, the
analysis of SAXS data for these samples did not give consistent results. This can be
due primarily to the fact that SAXS samples are much smaller than SANS samples and
therefore SAXS is more prone to sample inhomogeneity than SANS. Complications
also arise due to the viscosity of PEG solutions which can create more serious artifacts
for smaller samples.
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Fig. 4.9. SANS of A1AT in 50 wt% of PEG 1500.
Fig. 4.10. SANS of pre-diluted A1AT under osmotic stress at 30◦C.
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Fig. 4.11. Radius of gyration of A1AT as a function of PEG concentration
as determined from SANS data using Igor Pro Guinier fit.
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Fig. 4.12. SAXS measurements of A1AT in PEG 1500 solutions (upper
panel) and background scans (lower panel).
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4.3 A1AT and lipid
Scattering measurements of A1AT were also performed in the presence of lipid
vesicles to see if we can obtain aggregate materials in which the protein is incorporated
into lipid structures. Ion channel measurements in the lab that were not part of this
thesis project have showed that A1AT proteins affect the activity of gramicidin A
ion channels with a stronger affect for the negatively charged PS lipids compared to
neutral PC.
The approach for this study was the following. Because PC lipids in water form
multilamellar vesicles scattering measurements show characteristic Bragg peaks cor-
responding to the lamellar repeat (D-spacing). For POPC in water at 30◦C, there
are two Bragg peaks, one around Q = 0.1 A˚
−1
and the other at Q = 0.2 A˚
−1
. Because
there is no significant lipid scattering below Q = 0.1 A˚
−1
the protein scattering at
low Q can be distinguished from the lipid signal. By changing the amount of lipid
and protein, we can therefore investigate two main features of the scattering curves:
1) the relative scattering intensity of protein and lipid, and 2) possible shifts in the
location of lipid peaks. By observing these aspects we can determine if the A1AT
protein and the POPC lipid form mixed compounds.
The SAXS profiles in Fig. 4.13 show distinct scattering from the protein at lower
Q values (less than 0.1 A˚
−1
) and from lipid vesicles at larger Q values, as expected.
POPC lipids in water form multilamellar structures that typically exhibit two rela-
tively sharp scattering peaks as seen in Fig. 4.13. For pure POPC in water, these
peaks are narrow and sharp and the top of the peak is essentially Gaussian. How-
ever, when pH buffers are present as in these sample, peak line-shapes became more
complicated due to a coexistence of lamellar phases as described in [80].
The data in Fig. 4.13 show that scattering at low Q increases in proportion to
the amount of A1AT protein in the sample and at the same time leaving lipid peaks
unaffected. The most likely situation consistent with such a behavior is a complete
separation of lipid and protein phases.
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Fig. 4.13. SAXS measurements of samples containing A1AT protein and
POPC lipid vesicles in H2O 1XPBS solution at 30
◦C. The upper panel
shows the full measured range while the lower panel zooms on the 1st
lipid peak.
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A similar conclusion is reached based on SANS measurements as shown in Fig. 4.14.
No significant difference is observed in the lipid peak when comparing the scattering
with and without A1AT in D2O/H2O solutions chosen to match the scattering length
of the protein.
Fig. 4.14. SANS measurements of A1AT+POPC samples in 40%
D2O/H2O mixture and of POPC alone in 40% D2O/H2O and in 100%
D2O .
Measurements of A1AT in the presence of the negatively charge POPS lipid are
shown in Fig. 4.15 and Fig. 4.16 for SAXS and SANS, respectively.
Both sets of data indicate that A1AT affects the scattering profile of POPS. As op-
posed to POPC which forms multilamellar structures, the electrically charged POPS
tends to form unilamellar lipid vesicles. For this reason, POPS scattering shows a
broad scattering feature in the range .1 A˚
−1− .2 A˚−1 as seen in the figures. Depending
on the buffer solution and sample geometry, single vesicles can be found in coexistence
with a small fraction of multilamellar vesicles that produces Bragg peaks. Addition
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of A1AT reduces the amplitude of the broad lipid feature indicating mixing of POPS
single vesicles with A1AT.
Fig. 4.15. SAXS of POPS lipid and of POPS with A1AT.
Fig. 4.16 shows SANS of POPS in solution, and of POPS with A1AT while match-
ing protein to the background to observe POPS.
Measurements were also performed in the presence of DLPC lipid. DLPC is not
as biologically relevant as POPC but it is often used in measurements of membrane
interactions because it tends to give sharper scattering peaks than POPC under a
wide variety of conditions. Fig. 4.17 shows SAXS measurements of A1AT in the
presence of DLPC multilayers at T = 30◦ C.
Although the amplitude of the lipid peak changes, this change is not systematic
with the amount of A1AT, rather, we attribute this variation to variations in the
amount of lipid material localized in the x-ray beam.
We conclude that A1AT has a measurable effect in the scattering of PS and either
no effect (or under experimental detection limit) for the case of PC lipids.
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Fig. 4.16. SANS of POPS in solution, and POPS with A1AT while match-
ing protein to the background to observe POPS.
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Fig. 4.17. SAXS measurements of samples containing A1AT protein and
DLPC lipid vesicles in H2O 1XPBS solution at 30
◦C. The upper panel
shows the full measured range while the lower panel zooms on the 2nd
lipid peak.
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4.4 Fibrin polymerization
Fibrin measurements in this thesis where performed by SANS and by Dynamic
Light Scattering (DLS) as a function of time. Experiments were done using near
physiological concentrations of fibrinogen and thrombin (4 mg/ml to 5 mg/ml of
fibrinogen and 1 unit/µl of thrombin) and the goal was to follow the polymerization
reaction in real time. The detector used at the BL6 (EQ-SANS) allows the user to
accumulate scattering data over a long period of time and then go back and extract
specific time windows for analysis. EQ-SANS was set to use two wavelengths: 2.5 A˚
and 10 A˚, in order to capture a wider Q range. This arrangement allows the user to
better monitor the dynamic of protein polymerization growth. Two methods were
employed: the two wavelengths were used simultaneously (using frame skipping) when
capturing the dynamic evolution of the polymerization; and the two wavelengths use
one after the other (2.5 A˚, then 10 A˚) to capture a higher resolution picture of the
initial portion of the polymerization, while using the longer wavelength to capture the
end state of the polymerization. The scattering profiles shown in Fig.4.18 correspond
to 5 minute windows starting at the timepoints indicated by the labels, that is 5 to
10, 10 to 15, 15 to 20, and the 68-73 min, where 73 minutes was the total duration
of the scan. In the experiment, each measurement was set to a target number of
counts and therefore the exposure time was dependent on the state of the incident
neutron beam. The scattering profiles in Fig.4.18 are almost identical indicating that
no detectable structural changes occur after the first 5 minute interval. The only
possible explanation is that the polymerization reaction happened at a shorter time
scale.
In order to investigate reaction times in various conditions, we have performed
Dynamic Light Scattering (DLS) experiments. These are less powerful and less ac-
curate for measurements of polydispersed samples but more affordable than SANS.
These DLS measurements were performed to find the time scale of the polymerization
reaction in at various fibrinogen and thrombin concentrations in solution in order to
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Fig. 4.18. SANS of fibrin polymerization using 5 mg/ml fibrinogen and 1µl
of Thrombin (1 unit/µl), in 80% D2O solvent). Each profile is accumulated
over 5 minute time windows starting at the timepoints indicated by the
labels.
optimize the analysis of SANS data and to design future experiments. The EQ-SANS
(BL6) instrument at ORNL was used to redo the time resolved SANS experiments
using the following concentrations: fibrinogen at 0.4 mg/ml and 0.1µl of thrombin (1
unit/µl). DLS was used to determine the range of protein concentration for SANS
experiments. Using 4 mg/ml fibrinogen and and 0.01 u/ml thrombin yields about 90
minutes of reaction time. Measurements are shown in Fig. 4.19.
The DLS results indicate that fibrin polymerization completes in less than 10
minutes in our samples which unfortunately is too short for SANS. Although ap-
parent changes in size continue to occur even after 30 minutes, we attribute this to
sedimentation of large fibrin particles which are no longer in the path of the laser
beam.
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Fig. 4.19. Average size (diameter) of fibrin particles measured by DLS as
a function of time. Different curves correspond to different amounts of
fibrinogen (Fg) and thrombin (Thr) enzyme in the sample.
Fig. 4.20 shows another set of time resolved SANS measurements of Fibrin poly-
merization (4.25mg/ml Fg, 0.01 units/ml Th) in 1XPBS, 80% D2O .
Because of its larger size, the analysis of polymerized fibrin using standard meth-
ods is more complicated than for A1AT. Fig. 4.21 shows PDF of time resolved (PDF
of Fibrin Formation Kinetics: Monodisperse System of Rod-like Particles) SANS mea-
surements shows how the cross section of Fibrin changes as a function of time. The
analysis has been performed using GNOM.
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Fig. 4.20. SANS of fibrin polymerization using 4.25 mg/ml fibrinogen and
0.01 µl of Thrombin (1 unit/µl), in 80% D2O solvent). Each profile is
accumulated over various time intervals as shown on the legend.
Fig. 4.21. PDF of Fibrin Formation Kinetics obtain from a GNOM anal-
ysis.
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Fig. 4.22. SANS profiles for fibrinogen in water and in 40% PEG 1500.
4.5 Fibrinogen under osmotic pressure
Fig. 4.22 shows that osmotic pressure has an effect on fibrinogen polymerization.
The more abrupt decay of the scattering profile with increasing scattering angle indi-
cates larger aggregates in the presence of PEG. Note that the profile in the presence
of PEG is similar to those of polymerized fibrinogen in the presence of thrombin
enzyme.
PDF analysis of fibrinogen scattering under osmotic stress using GNOM and using
either a monodispersed system of rod-like particles or sphere-like particles are shown
in Fig.4.23. These PDFs show how osmotic stress affects the size and structure of
Fibrinogen’s envelope shape, when treated as a particle.
The analysis is done using the Large Scale Structure analysis procedure which
gives the distance distribution function of the cross-section assuming monodisperse
system of rod-like particles. The function P (r) = γc(r)∗ r is evaluated, where γc(r) is
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Fig. 4.23. Analysis of fibrinogen under osmotic stress using GNOM for a
rod-like model (upper panel) and a sphere-like model (lower panel).
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the characteristic function of thickness. In this case the experimental intensity as well
as the errors are multiplied by s, which corresponds to the cross-section scattering
factor.
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5. DISCUSSION
For proteins in solution, scattering methods do not provide a 3D atomic structure
as one might obtain from computer simulations either alone or in combination with
solution NMR measurements. Instead, scattering methods as presented in this work
can give information on structural variations due to changes in external conditions.
Scattering methods can also be an indirect but efficient way of identifying molecular
affinities, miscibility, and possible coexistence of phases as in the study of A1AT
interacting with lipid vesicles.
Fibrinogen and Alpha 1-Antitrypsin (A1AT) are plasma glycoproteins with dif-
ferent, but specific biological functions. A1AT has been shown to have protective
roles of lung cells against emphysema, while fibrinogen is a major factor in the blood
clotting process. Most known glycoproteins have been shown to play a role in cellular
interactions but the exact role of the glycan chains which are not visible to small-angle
scattering is still under investigation.
The main questions addressed through the measurements presented in this thesis
are the following: 1) What structural changes of large protein aggregates take place
either as a function of time or under osmotic pressure? 2) How do large protein struc-
tures interact with lipid vesicles? and 3) Can we monitor and optimize polymerization
conditions for proteins such as fibrinogen?
The motivation for 1) and 3) was due to questions regarding the ability to observe
structural changes in large molecular aggregates by standard scattering methods. The
motivation for the 2nd aspect is due to observations of A1AT interaction with lipid
membranes used in ion channel measurements in our laboratory (data not shown).
It was observed that A1AT affects gramicidin ion channels more when embedded in
phosphatidylserine (PS) lipid bilayers than in phosphatidylcholine (PC).
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A major aspect of this work is finding optimum sample preparation protocols. As
shown above, due to sample inhomogeneity, there is a non-trivial effect of sample
history which is more pronounced for fibrinogen than for A1AT due to its larger size.
There are also noticeable differences between SAXS and SANS results which arise
primarily for two reasons. One is that the time scale of the measurement with scan
times on the order of a second or less in the case of SAXS compared to half an hour for
SANS. The second reason for the observed differences is the relationship between the
cross-section of the beam and the sample physical size. Synchrotron x-ray beams are
on the order of a millimeter or less in diameter compared to centimeter for neutrons.
This means that SANS sees a much larger fraction of the sample compared to SAXS.
In combination with longer exposure times, SANS data then correspond to averaging
over imhomogeneities to a much larger degree than in SAXS. For this reason, it was
found that in the case of fibrinogen, SANS measurements needed to be supplemented
with DLS measurements which are both faster and operating at larger length scales.
For A1AT, we find that a structural transition occurs under osmotic stress applied
using PEG. This transition is between 33 wt% PEG and 36 wt% PEG in solution,
when fitting for the radius of gyration using Guinier fit (Igor Pro; ORNL package).
There are two regions of linear relationship between Rg and PEG concentration. It is
also worth noticing that the jump in Rg after 33% is about double, and then triple for
50% wt% PEG. This can possibly be forced aggregation. This could then be compared
to the concentration series to find out if crowding has the same effect, or if the effect
of compression and aggregation is not seen even at 50 mg/ml A1AT concentration.
We also found that there was no change in protein structure or aggregation due to
changes in protein concentration, within the range explored: 1 mg/ml to 50 mg/ml
(Fig. 4.1). Technically however, there was a disagreement between the three different
methods used to determine the Rg at lower concentrations (Fig. 4.6) most likely due
to a small signal-to-noise ratio at low protein concentration.
A linear fit through the first five data points in Fig. 5.1 that correspond to the
protein compression under osmotic stress gives Rg = −0.2189x + 35.652, where x
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stands for PEG wt%. We can use this linear form to find a theoretical value for PEG
concentration that would correspond to the calculated Rg = 21.2 A˚ for the x-ray
crystal structure (2QUG) (Fig. 1.1). The linear extrapolation gives a concentration
of PEG of about 66 wt%. Obviously, as shown in Fig. 4.10, the protein does not
shrink to this small size under physiological conditions; rather as PEG concentration
increases above 35 %, we see a major structural change indicating protein aggregation
in larger units which makes it impossible to determine the Rg values for individual
protein units.
Fig. 5.1. Radius of gyration of A1AT as a function of PEG concentration
as determined from SANS data using Igor Pro Guinier fit. The figure
shows a linear fit to the compression regime at low osmotic pressure and
the shading indicates protein aggregation.
Our analysis also shows that the fitted Q range directly affects the results of the
analysis. If the range is not explored to ensure consistency, the results may not be
correct or accurate. In this case the range needed a Qmax higher than 0.30 A˚
−1
.
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An additional complication for SAXS samples containing PEG and A1AT was due
to background subtraction needed to eliminate the contribution from PEG. This was
due to the non-linear scattering profile from the gel material formed by PEG when
hydrated. In this respect, SANS can be a better method since scattering from PEG
can be eliminated (or at least minimized) using contrast matching. The best method
for analysis was to match the solvent curve to the full sample curve at a Q range
between 0.3 A˚
−1
and 0.5 A˚
−1
then subtract the background. A constant background
subtraction was needed when doing the analysis in programs other than SasView (as
SasView would identify the constant background and account for it), like Igor Pro
and GNOM. An accurate background subtraction was not possible when using SAXS
for samples containing A1AT and PEG.
Turning to SANS, the measured radius of gyration for A1AT differs between the
protein sample in 100% D2O (22.8 A˚±0.035 A˚) and the sample in 16% D2O (27.1 A˚±
0.35 A˚) and the origin of this 4.3 A˚ difference is not exactly clear. It could be due to
sensitivity to contrast and therefore an experimental artifact, or it could be due to a
change in dynamics (and therefore sample history) as a function of D2O content.
For both SAXS and SANS, when preparing the samples of A1AT and PEG, it
was found that the best method was to pre-dilute each solute individually, then mix
the two solutions rather than adding the solutes to the same solvent in one vial.
Supernatant was an issue when A1AT was added to PEG in solution which meant
that the resulting mixture was not homogeneous.
Sample history turned out to be even more complicated in the case of fibrino-
gen. [81–84] Under physiological concentrations of fibrinogen and thrombin, it takes
between 3 and 5 minutes to form the fibrin network. The challenge to study the
formation of a fibrin clot is that SAXS (at Argonne) will produce radiation damage
if there is prolonged exposure (more than 100 ms), while SANS (at EQ-SANS) will
not capture the kinetic evolution of the formation because it needs at least 15 to 20
minutes of beam time in order to create a sufficient signal to noise ratio. Dynamic
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Light Scattering was a necessary method in finding a lower concentration that would
yield a 90 minute kinetic evolution of the fibrin clot in order to be captured by SANS.
An interesting finding is the fact that SANS measurements of fibrinogen under
osmotic pressure show that the scattering of fibrinogen in 40% PEG but without the
thrombin enzyme is similar to that of fully formed fibrin in the presence of thrombin
and no PEG. This result suggests a possible research avenue for the analysis of blood
clot formation in various physiological conditions in which alteration of solute con-
centrations in blood and in the extracellular matrix can affect the dynamics of clot
formation.
Similarly interesting is the finding that although A1AT does not visibly mix with
lipids, SAXS measurements do detect the preference of A1AT to PS lipid compared to
PC. This preference can be exploited in possible medical applications using liposomes
for supplementing A1AT into the blood stream of patients with A1AT deficiency.
Currently, one therapy for the treatment of A1AT deficiency uses blood plasma of
healthy human donors to increase the alpha-1 levels circulating in the blood and
lungs of patients (a therapy called augmentation therapy.) [49–51,85–90] In principle,
pharmaceutical methods could be explored using A1AT complexes with PS lipids.
A more general discussion of protein deformation under osmotic stress can be
warranted based on the results presented in this thesis. In principle, using osmotic
pressure data, an energy scale for protein deformation can be obtained and the protein
can be use as a biophysical probe in various environments. By placing a protein’s
structural deformation on a calibrated energy scale allows one to characterize and
compare various environments. At a much different scale such an approach has been
used to characterize the environment of amino acids using NMR spectroscopy [91].
Because of its larger size, and due to the possibility of anisotropic deformations,
a test protein can offer some interesting applications. In our approach we essentially
measure strain (deformation) under osmotic stress. This is accomplished by adding
osmolytes such as polyethylene glycol (PEG) to the protein sample. In practice, any
deformation force acts over a surface (as opposed to a single point) and therefore it is
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appropriate to describe it as a pressure (force per unit area) or stress as in the context
of material research. The resulting deformation under external stress is called strain.
Stress-strain curves and Poisson’s ratios that measure anisotropic deformations can
provide a set of data that can be useful in material characterization. Deformation
models can then be used in conjunction with the shape-dependent models that are
currently used to fit scattering data as for example in Fig. 4.7 in this thesis. A shape
affinity mapping can be created using the chi-squared reduced value from each fit.
Such a combined approach can become a tool for describing possible transitions of
shapes for a structure under study. The tool is still under development, but essen-
tially it is a matrix of relative confidence levels from all possible (or most likely)
shape models. The goals are to avoid assumptions that may lead to an incorrect or
incomplete picture, to provide a landscape of the confidence levels for each potential
model, to describe structures that fit more than one shape model in a way that is
more representative of reality. Such an approach can be applied to other materials
not just proteins.
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6. CONCLUSIONS
In conclusion, we have shown that although scattering data from large protein ag-
gregates such as A1AT and fibrinogen are difficult to analyze; by combining SAXS,
SANS, and DLS methods we can obtain structural information that is otherwise in-
accessible. Specifically, we have seen that osmotic stress can induce the aggregation
of both A1AT and of fibrinogen. In the case of A1AT under osmotic stress we have
identified two deformation regimes, namely a compression under lower stress values
followed by abrupt aggregation at high stress. For fibrinogen we induced polymer-
ization using the enzyme thrombin and measured characteristic scattering for fibrin
networks. We then showed that high osmotic stress produces scattering curves similar
to fibrin scattering.
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PRESS & MEDIA
Promising Practice: Health and Science Innovations’Young Innovators Quest Pro-
gram; Indiana Pathways Innovation Network; August, 2016. Preparing the Next Gen-
eration of Innovators. Embrace Diversity Magazine; Fall 2015, p. 4.
Ph.D. Physics Student Urges Members of Congress to Support Science and Tech-
nology Research. Inside IUPUI Editor’s Pick; July 9, 2013.
STEM Fellows: Science Grad Students Promote Science to Local Students. Indi-
anapolis Star; June 4, 2012, front page.
ADDITIONAL TRAINING
• Indiana Professional Engineering License, PE10606511 (2006 - Present).
• Neutrons in Biology, by ORNL and North Carolina State University (2016).
• Frontiers in Neutron Structural Biology, by Oak Ridge National Laboratories
(2013).
• Presentation Boot Camp Workshop, by Dr. Richard Tankersley (2012).
• Social/Behavioral Researchers, Human Research 2 Curriculum, by the Collabo-
rative Institutional Training Initiative (2012), for Internal Review Board inves-
tigator approval.
• Lubrication Analysis for Bearings (2003).
• Vibration Analysis of Rotating Machinery (2003).
• ANSYS Introductory Course by GE Canada (2003).
• Bearing Selection, Design and Failure Analysis (2002).
• Six Sigma Methodology; Green Belt certified by GE (2001); last project com-
pleted in Feb. 2016.
76
ACADEMIC EXPERIENCE
01/2009–Present Ion Channels and Lipid Membrane Structure
Use physical methods to study the structural parameters of lipid membranes and how
these membranes interact with proteins of interest under different conditions. Meth-
ods include: small angle x-ray scattering, neutron scattering, lipid bi-layer ion chan-
nel current measurements, light scattering, zeta-potential measurements and micro-
fluidic devices.
01/2006–12/2007 Protein Knowledge Based Potential (M.S. Thesis)
Used computational methods to study how to improve protein knowledge based po-
tentials for coarse grained models by testing traditional fundamental assumptions
like the application of the Boltzmann distribution to amino acids pairwise distances
of crystallized proteins in order to extract pairwise potentials and predict protein
folding.
01/2004–05/2004 Resonance
Studied the resonance phenomenon through research and experimentation of mechan-
ical vibration, RLC circuit resonance and electron spin resonance.
08/2003–12/2003 Atomic and Molecular Spectroscopy
Studied spectroscopy through research and experimentation. Created a digital spec-
trograph able to measure relative intensity and wavelengths of a given line spectrum.
08/1999–12/1999 Finite Element Analysis
CAD structural analysis project. Created a program in Matlab able to calculate the
strains and stresses of a given solid structure.
01/1998–05/1998 House Construction based on Heating and Cooling Load
HVAC design project
Calculated the heating and cooling loads, and selected construction materials for a
given house plan located in Indiana.
01/1998–05/1998 Catamaran Hull Outboard Motor Redesign
Fluid mechanics project. Investigated the cause of poor propeller performance of a
Harris Kayot catamaran boat, suggested possible solutions, and built a prototype.
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SELECTED AWARDS
• United Way (UWCI) IMPACT in Education Awards for Tech Literacy, 2018.
• Skill UP 3 Indiana Workforce Development Grant ($931k), 2018.
• Skill UP 2 Indiana Workforce Development Grant ($532k), 2016.
• Nominee for AAAS/Science Program for Excellence in Science, 2016–2018.
• Five beam time awards for experiments at EQ-SANS (BL6), Oak Ridge National
Laboratory (ORNL), 2011–2014.
• National Science Foundation GK-12 Fellowship, 2011–2013.
• Southern Regional Education Board Dissertation Scholar, 2011–2013.
• Indiana University Research Investment Fund Fellowship,2004–2005.
IMPACT & MENTORING:
• 600 Elementary school students learning tech, or working on science fair projects.
• 240 High school students through STEM Programs.
• 190 Undergraduate students in physics (mechanics) labs, and 4 preparing for the
MCAT.
• 19 Science and engineering undergraduate students working in various research
projects.
• 3 Undergraduate engineering students at General Electrical (COOP).
• 2 Electrical Engineering graduate students working on biomedical communica-
tions systems.
• 1 Physics Post-Doc at Oak Ridge National Laboratory.
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COMMUNITY ENGAGEMENT
• Advocacy for importance of scientific research to U.S. Congress members
• IUPUI, School of Science Diversity Council
• Marian University Hispanic Advisory Board
• Indiana After-school Network STEM Taskforce
• Indiana Senate Latino Roundtable
• Science Olympiad IUPUI Invitational Master of Ceremony
• 2016 Central Indiana Regional Science and Engineering Fair Judge
• Gleaners Food Bank of Indiana Volunteer
• Million Meals Marathon Indianapolis Volunteer
MEMBERSHIP, BOARDS AND COMMITTEES
• Society of Hispanic Professional Engineers (SHPE); Co-chair of SHPE Jr., Indi-
ana Chapter
• Indiana Academy of Science; Member of Membership Advisory Committee
• Biophysical Society
• American Association for the Advancement of Science (AAAS)
• National User Facility Organization (NUFO)
• American Physical Society (APS)
• National Society of Hispanic Physicists (NSHP)
• National Science Teachers Association (NSTA)
